• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲病毒进入和抗体保护的分子机制研究。

A molecular understanding of alphavirus entry and antibody protection.

机构信息

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

出版信息

Nat Rev Microbiol. 2023 Jun;21(6):396-407. doi: 10.1038/s41579-022-00825-7. Epub 2022 Dec 6.

DOI:10.1038/s41579-022-00825-7
PMID:36474012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9734810/
Abstract

Alphaviruses are arthropod-transmitted RNA viruses that cause epidemics of human infection and disease on a global scale. These viruses are classified as either arthritogenic or encephalitic based on their genetic relatedness and the clinical syndromes they cause. Although there are currently no approved therapeutics or vaccines against alphaviruses, passive transfer of monoclonal antibodies confers protection in animal models. This Review highlights recent advances in our understanding of the host factors required for alphavirus entry, the mechanisms of action by which protective antibodies inhibit different steps in the alphavirus infection cycle and candidate alphavirus vaccines currently under clinical evaluation that focus on humoral immunity. A comprehensive understanding of alphavirus entry and antibody-mediated protection may inform the development of new classes of countermeasures for these emerging viruses.

摘要

甲病毒是节肢动物传播的 RNA 病毒,可在全球范围内引起人类感染和疾病的流行。这些病毒根据其遗传关系和引起的临床综合征分为关节炎型或脑炎型。尽管目前尚无针对甲病毒的批准疗法或疫苗,但单克隆抗体的被动转移可在动物模型中提供保护。本综述强调了我们对甲病毒进入宿主所需的宿主因素以及保护性抗体抑制甲病毒感染周期不同步骤的作用机制的最新理解方面的最新进展,以及当前正在临床评估的专注于体液免疫的候选甲病毒疫苗。对甲病毒进入和抗体介导的保护的全面了解可能为这些新兴病毒的新对策的开发提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/9734810/a4610a7d71dd/41579_2022_825_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/9734810/b7dc63878666/41579_2022_825_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/9734810/a4610a7d71dd/41579_2022_825_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/9734810/b7dc63878666/41579_2022_825_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/9734810/a4610a7d71dd/41579_2022_825_Fig2_HTML.jpg

相似文献

1
A molecular understanding of alphavirus entry and antibody protection.甲病毒进入和抗体保护的分子机制研究。
Nat Rev Microbiol. 2023 Jun;21(6):396-407. doi: 10.1038/s41579-022-00825-7. Epub 2022 Dec 6.
2
Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targets.抗关节炎甲病毒的抗病毒药物研发:工具和分子靶标。
Biochem Pharmacol. 2020 Apr;174:113777. doi: 10.1016/j.bcp.2019.113777. Epub 2019 Dec 23.
3
Animal models of alphavirus infection and human disease.虫媒病毒感染的动物模型与人类疾病。
Adv Virus Res. 2022;113:25-88. doi: 10.1016/bs.aivir.2022.07.001. Epub 2022 Aug 22.
4
Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.基于新型昆虫特异性埃拉特病毒的嵌合疫苗候选物可提供持久的单剂量和多价保护,抵御致死性甲病毒攻击。
J Virol. 2018 Jan 30;92(4). doi: 10.1128/JVI.01274-17. Print 2018 Feb 15.
5
Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.接近种系的人源单克隆抗体可中和并预防多种致关节炎的甲病毒。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2100104118.
6
Insect-Specific Chimeric Viruses Potentiated Antiviral Responses and Inhibited Pathogenic Alphavirus Growth in Mosquito Cells.昆虫特异性嵌合病毒增强了抗病毒反应并抑制了蚊细胞中的致病性甲病毒生长。
Microbiol Spectr. 2023 Feb 14;11(1):e0361322. doi: 10.1128/spectrum.03613-22. Epub 2022 Dec 13.
7
Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives.脑炎病毒感染的非人灵长类动物模型:历史回顾与未来展望。
Curr Opin Virol. 2012 Jun;2(3):363-7. doi: 10.1016/j.coviro.2012.02.014. Epub 2012 Mar 21.
8
Entry receptors - the gateway to alphavirus infection.进入受体——甲病毒感染的门户。
J Clin Invest. 2023 Jan 17;133(2):e165307. doi: 10.1172/JCI165307.
9
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.广谱中和性甲病毒抗体结合 E2 上的一个表位,并抑制进入和离开。
Cell. 2015 Nov 19;163(5):1095-1107. doi: 10.1016/j.cell.2015.10.050. Epub 2015 Nov 6.
10
Distinct Cellular Tropism and Immune Responses to Alphavirus Infection.甲病毒感染的独特细胞嗜性和免疫反应。
Annu Rev Immunol. 2022 Apr 26;40:615-649. doi: 10.1146/annurev-immunol-101220-014952. Epub 2022 Feb 8.

引用本文的文献

1
Determinants of human versus mosquito cell entry by the Chikungunya virus envelope proteins.基孔肯雅病毒包膜蛋白进入人类细胞与蚊子细胞的决定因素。
bioRxiv. 2025 Aug 25:2025.08.25.672233. doi: 10.1101/2025.08.25.672233.
2
Insights into the Landscape of Alphavirus Receptor and Antibody Interactions.深入了解甲病毒受体与抗体相互作用的格局
Viruses. 2025 Jul 21;17(7):1019. doi: 10.3390/v17071019.
3
Granulocyte colony-stimulating factor protects against acute systemic alphavirus disease in a type I IFN-dependent manner.粒细胞集落刺激因子以I型干扰素依赖的方式预防急性全身性甲病毒疾病。

本文引用的文献

1
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.肌肉注射 AZD7442(替沙格韦单抗-西加韦单抗)预防新冠病毒感染。
N Engl J Med. 2022 Jun 9;386(23):2188-2200. doi: 10.1056/NEJMoa2116620. Epub 2022 Apr 20.
2
Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.中和抗体可保护小鼠免受委内瑞拉马脑炎病毒气溶胶攻击。
J Exp Med. 2022 Apr 4;219(4). doi: 10.1084/jem.20212532. Epub 2022 Mar 17.
3
Distinct Cellular Tropism and Immune Responses to Alphavirus Infection.甲病毒感染的独特细胞嗜性和免疫反应。
Front Immunol. 2025 Jul 11;16:1606053. doi: 10.3389/fimmu.2025.1606053. eCollection 2025.
4
Progress in Pseudotyping Lentiviral Vectors Towards Cell-Specific Gene Delivery In Vivo.慢病毒载体假型化用于体内细胞特异性基因递送的研究进展
Viruses. 2025 May 31;17(6):802. doi: 10.3390/v17060802.
5
Mammalian fatty acid synthase: a commonly used viral host dependency factor and a putative target for host-targeted broad-spectrum antiviral therapeutic development.哺乳动物脂肪酸合酶:一种常用的病毒宿主依赖因子以及宿主靶向广谱抗病毒治疗研发的潜在靶点。
mBio. 2025 Aug 13;16(8):e0395424. doi: 10.1128/mbio.03954-24. Epub 2025 Jun 25.
6
Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease.CCL4及其受体CCR5在致关节炎甲病毒疾病中不存在致病性参与。
Immunohorizons. 2025 May 30;9(7). doi: 10.1093/immhor/vlaf022.
7
Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus.针对委内瑞拉马脑炎病毒的单域抗体的生成式深度学习设计
Antibodies (Basel). 2025 May 14;14(2):41. doi: 10.3390/antib14020041.
8
Highly Potent Neutralizing Nanobodies Acting Against Chikungunya Virus Infection via Inhibiting Multiple Stages of the Viral Life Cycle.通过抑制基孔肯雅病毒生命周期的多个阶段来对抗基孔肯雅病毒感染的高效中和纳米抗体
Int J Mol Sci. 2025 Apr 23;26(9):3982. doi: 10.3390/ijms26093982.
9
Engineered antibody-mediated broad-spectrum suppression of human arboviruses in the Aedes aegypti vector.工程化抗体介导的埃及伊蚊载体中人类虫媒病毒的广谱抑制
Commun Biol. 2025 May 7;8(1):709. doi: 10.1038/s42003-025-08133-5.
10
CHIKV mRNA vaccines encoding conserved structural/envelope proteins confer broad cross-lineage protection against infection.编码保守结构/包膜蛋白的基孔肯雅病毒信使核糖核酸疫苗可提供广泛的跨谱系感染防护。
Signal Transduct Target Ther. 2025 Mar 28;10(1):98. doi: 10.1038/s41392-025-02182-2.
Annu Rev Immunol. 2022 Apr 26;40:615-649. doi: 10.1146/annurev-immunol-101220-014952. Epub 2022 Feb 8.
4
VLDLR and ApoER2 are receptors for multiple alphaviruses.VLDLR 和 ApoER2 是多种甲病毒的受体。
Nature. 2022 Feb;602(7897):475-480. doi: 10.1038/s41586-021-04326-0. Epub 2021 Dec 20.
5
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.一项针对脂质包裹的编码具有中和抗基孔肯雅病毒活性的单克隆抗体的 mRNA 的 1 期临床试验。
Nat Med. 2021 Dec;27(12):2224-2233. doi: 10.1038/s41591-021-01573-6. Epub 2021 Dec 9.
6
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.Sotrovimab 对 SARS-CoV-2 中和抗体用于治疗新型冠状病毒早期感染。
N Engl J Med. 2021 Nov 18;385(21):1941-1950. doi: 10.1056/NEJMoa2107934. Epub 2021 Oct 27.
7
Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3.委内瑞拉马脑炎病毒与其受体 LDLRAD3 的结构。
Nature. 2021 Oct;598(7882):677-681. doi: 10.1038/s41586-021-03909-1. Epub 2021 Oct 13.
8
Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor. Venezuelan equine encephalitis virus 与 LDLRAD3 受体复合物的结构。
Nature. 2021 Oct;598(7882):672-676. doi: 10.1038/s41586-021-03963-9. Epub 2021 Oct 13.
9
Infectious disease in an era of global change.全球变化时代的传染病
Nat Rev Microbiol. 2022 Apr;20(4):193-205. doi: 10.1038/s41579-021-00639-z. Epub 2021 Oct 13.
10
Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.在使用黄病毒交叉反应性单克隆抗体治疗之前,暴露委内瑞拉马脑炎病毒 E1 糖蛋白上的隐匿表位,可在感染早期阻止病毒复制。
Virology. 2022 Jan 2;565:13-21. doi: 10.1016/j.virol.2021.09.007. Epub 2021 Sep 28.